Surfactant Replacement Therapy for Severe Neonatal Respiratory Distress Syndrome: An International Randomized Clinical Trial

In a randomized multicenter trial, involving the collaboration of eight European neonatal intensive care units, the efficacy of replacement therapy with a new surfactant preparation (Curosurf) was tested in 146 patients with severe neonatal respiratory distress syndrome. Criteria for entry included birth weight 700 to 2,000 g, age when treated two to 15 hours, and requirement of artificial ventilation with Fio₂ 0.6. The babies were treated with a single large dose of surfactant (200 mg/kg) at a median age of nine hours (range two to 15 hours). Average Fio₂ before treatment was the same (0.80) for both surfactant-treated patients and control patients. Babies receiving surfactant showed, within five minutes, a dramatic improvement of oxygenation as reflected by a nearly threefold increase of the Pao₂/Fio₂ ratio. Six hours after randomization, the Pao₂/Fio₂ ratio still showed a 98% improvement in surfactant-treated patients compared with controls (P < .001), and statistically significant differences in favor of the treated babies persisted until 48 hours after randomization, when surviving control infants began to recover. Treatment with surfactant decreased neonatal (28 days) mortality from 51% to 31% (P < .05). Compared with control babies, the surfactant-treated group also had a decreased incidence of pulmonary interstitial emphysema (23% v 39%; P < .05) and pneumothorax (18% v 35%; P < .05). The percentage of survivors without bronchopulmonary dysplasia in the treated group was more than twice that of the control group (55% v 26%; P < .001). Treatment with this surfactant appears to effectively improve lung function and short-term outcome in infants with severe respiratory distress syndrome.

Key Words: surfactant replacement therapy • neonatal respiratory distress syndrome

Submitted on January 19, 1988
Accepted on March 29, 1988

This article has been cited by other articles:

				W. A. Engle and and the Committee on Fetus and Newborn Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate Pediatrics, February 1, 2008; 121(2): 419 - 432. [Abstract] [Full Text] [PDF]

				A. Valls-i-Soler, H. L. Halliday, and H. Hummler International Perspectives: Neonatal Networking: A European Perspective NeoReviews, July 1, 2007; 8(7): e275 - e281. [Full Text] [PDF]

				E. Gastiasoro-Cuesta, F. J. Alvarez-Diaz, C. Rey-Santano, A. Arnaiz-Renedo, B. Loureiro-Gonzalez, and A. Valls-i-Soler Acute and Sustained Effects of Lucinactant Versus Poractant-{alpha} on Pulmonary Gas Exchange and Mechanics in Premature Lambs With Respiratory Distress Syndrome Pediatrics, February 1, 2006; 117(2): 295 - 303. [Abstract] [Full Text] [PDF]

				B. N. Shashikant, T. L. Miller, R. W. Welch, A. L. Pilon, T. H. Shaffer, and M. R. Wolfson Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles J Appl Physiol, December 1, 2005; 99(6): 2204 - 2211. [Abstract] [Full Text] [PDF]

				S. K. Sinha, T. Lacaze-Masmonteil, A. Valls i Soler, T. E. Wiswell, J. Gadzinowski, J. Hajdu, G. Bernstein, M. Sanchez-Luna, R. Segal, C. J. Schaber, et al. A Multicenter, Randomized, Controlled Trial of Lucinactant Versus Poractant Alfa Among Very Premature Infants at High Risk for Respiratory Distress Syndrome Pediatrics, April 1, 2005; 115(4): 1030 - 1038. [Abstract] [Full Text] [PDF]

				J. Kattwinkel Synthetic Surfactants: The Search Goes on Pediatrics, April 1, 2005; 115(4): 1075 - 1076. [Full Text] [PDF]

				S. E. Welty Is There a Role for Antioxidant Therapy in Bronchopulmonary Dysplasia? J. Nutr., March 1, 2001; 131(3): 947S - 950. [Abstract] [Full Text]

				E. Herting, O. Gefeller, M. Land, L. van Sonderen, K. Harms, B. Robertson, and Members of the Collaborative European Multicenter Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection Pediatrics, November 1, 2000; 106(5): 957 - 964. [Abstract] [Full Text]

				J H Baumer International randomised controlled trial of patient triggered ventilation in neonatal respiratory distress syndrome Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2000; 82(1): 5F - 10. [Abstract] [Full Text]

				E. HERTING, X. GAN, P. RAUPRICH, C. JARSTRAND, and B. ROBERTSON Combined Treatment with Surfactant and Specific Immunoglobulin Reduces Bacterial Proliferation in Experimental Neonatal Group B Streptococcal Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1862 - 1867. [Abstract] [Full Text]

				J. López-Herce, N. de Lucas, A. Carrillo, A. Bustinza, and R. Moral Surfactant treatment for acute respiratory distress syndrome Arch. Dis. Child., March 1, 1999; 80(3): 248 - 252. [Abstract] [Full Text]

				H. Verder, P. Albertsen, F. Ebbesen, G. Greisen, B. Robertson, A. Bertelsen, L. Agertoft, B. Djernes, E. Nathan, and J. Reinholdt Nasal Continuous Positive Airway Pressure and Early Surfactant Therapy for Respiratory Distress Syndrome in Newborns of Less Than 30 Weeks' Gestation Pediatrics, February 1, 1999; 103(2): 24e - 24. [Abstract] [Full Text]

				A. Valls-i-Soler, B. Fernandez-Ruanova, J. L.-H. y Goya, L. R. Etxebarria, J. Rodriguez-Soriano, V. Carretero [Caceres], and Spanish Surfactant Collaborative Group A Randomized Comparison of Surfactant Dosing via a Dual-lumen Endotracheal Tube in Respiratory Distress Syndrome Pediatrics, April 1, 1998; 101 (4): e4 - e4. [Abstract] [Full Text] [PDF]

				M. L. Hudak, D. J. Martin, E. A. Egan, E. J. Matteson, J. Cummings, A. L. Jung, L. V. Kimberlin, R. L. Auten, A. A. Rosenberg, J. M. Asselin, et al. A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress Syndrome Pediatrics, July 1, 1997; 100(1): 39 - 50. [Abstract] [Full Text] [PDF]

				J. Egberts, R. Brand, H. Walti, G. Bevilacqua, G. B. MD, and F. Gardini Mortality, Severe Respiratory Distress Syndrome, and Chronic Lung Disease of the Newborn Are Reduced More After Prophylactic Than After Therapeutic Administration of the Surfactant Curosurf Pediatrics, July 1, 1997; 100(1): e4 - e4. [Abstract] [Full Text] [PDF]

				D. C Wilson, P. Cairns, H. L Halliday, M. Reid, G. McClure, and J. A Dodge Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1997; 77(1): 4F - 11. [Abstract] [Full Text]

				C J Morley Systematic review of prophylactic vs rescue surfactant Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1997; 77(1): 70F - 74. [Full Text]

				R F Maier, M Rey, B C Metze, M Obladen;, and W. TARNOW-MORDI Comparison of mortality risk: a score for very low birthweight infants • Commentary Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1997; 76(3): 146F - 151. [Abstract] [Full Text]

				E. Herting, B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 3F - 8. [Abstract] [Full Text]

				H. Verder, B. Robertson, G. Greisen, F. Ebbesen, P. Albertsen, K. Lundstrom, T. Jacobsen, and The Danish-Swedish Multicenter Study Group Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome N. Engl. J. Med., October 20, 1994; 331(16): 1051 - 1055. [Abstract] [Full Text]

				R. M. Schwartz, A. M. Luby, J. W. Scanlon, and R. J. Kellogg Effect of Surfactant on Morbidity, Mortality, and Resource Use in Newborn Infants Weighing 500 to 1500 g N. Engl. J. Med., May 26, 1994; 330(21): 1476 - 1480. [Abstract] [Full Text]

				M. E. Msall, G. M. Buck, B. T. Rogers, L. C. Duffy, S. R. Mallen, and N. L. Catanzaro Predictors of Mortality, Morbidity, and Disability in a Cohort of Infants <= 28 Weeks' Gestation Clinical Pediatrics, September 1, 1993; 32(9): 521 - 527. [Abstract] [PDF]

				A. H. Jobe Pulmonary Surfactant Therapy N. Engl. J. Med., March 25, 1993; 328(12): 861 - 868. [Full Text]

				D. D. Berry Neonatology in the 1990's: Surfactant Replacement Therapy Becomes a Reality Clinical Pediatrics, March 1, 1991; 30(3): 167 - 172. [Abstract] [PDF]

				SURFACTANT-REPLACEMENT THERAPY FOR NEONATAL RESPIRATORY DISTRESS SYNDROME Journal Watch (General), November 25, 1988; 1988(1125): 4 - 4. [Full Text]